177 related articles for article (PubMed ID: 34091930)
1. Characterization of the HollandPTC proton therapy beamline dedicated to uveal melanoma treatment and an interinstitutional comparison.
Fleury E; Trnková P; Spruijt K; Herault J; Lebbink F; Heufelder J; Hrbacek J; Horwacik T; Kajdrowicz T; Denker A; Gerard A; Hofverberg P; Mamalui M; Slopsema R; Pignol JP; Hoogeman M
Med Phys; 2021 Aug; 48(8):4506-4522. PubMed ID: 34091930
[TBL] [Abstract][Full Text] [Related]
2. Design and commissioning of the non-dedicated scanning proton beamline for ocular treatment at the synchrotron-based CNAO facility.
Ciocca M; Magro G; Mastella E; Mairani A; Mirandola A; Molinelli S; Russo S; Vai A; Fiore MR; Mosci C; Valvo F; Via R; Baroni G; Orecchia R
Med Phys; 2019 Apr; 46(4):1852-1862. PubMed ID: 30659616
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric properties of a proton beamline dedicated to the treatment of ocular disease.
Slopsema RL; Mamalui M; Zhao T; Yeung D; Malyapa R; Li Z
Med Phys; 2014 Jan; 41(1):011707. PubMed ID: 24387499
[TBL] [Abstract][Full Text] [Related]
4. Monte Carlo calculations and measurements of absorbed dose per monitor unit for the treatment of uveal melanoma with proton therapy.
Koch N; Newhauser WD; Titt U; Gombos D; Coombes K; Starkschall G
Phys Med Biol; 2008 Mar; 53(6):1581-94. PubMed ID: 18367789
[TBL] [Abstract][Full Text] [Related]
5. Optimization of FLASH proton beams using a track-repeating algorithm.
Wang Q; Titt U; Mohan R; Guan F; Zhao Y; Yang M; Yepes P
Med Phys; 2022 Oct; 49(10):6684-6698. PubMed ID: 35900902
[TBL] [Abstract][Full Text] [Related]
6. Design and characterization of an aperture system and spot configuration for ocular treatments with a gantry-based spot scanning proton beam.
Hickling SV; Corner S; Kruse JJ; Deisher AJ
Med Phys; 2023 Jul; 50(7):4521-4532. PubMed ID: 37084072
[TBL] [Abstract][Full Text] [Related]
7. Improving organs-at-risk sparing for choroidal melanoma patients: A CT-based two-beam strategy in ocular proton therapy with a dedicated eyeline.
Fleury E; Trnková P; van Rij C; Rodrigues M; Klaver Y; Spruijt K; Naus N; Zolnay A; Pignol JP; Kiliç E; Hoogeman MS
Radiother Oncol; 2022 Jun; 171():173-181. PubMed ID: 35487435
[TBL] [Abstract][Full Text] [Related]
8. Ocular proton therapy, pencil beam scanning high energy proton therapy or stereotactic radiotherapy for uveal melanoma; an in silico study.
Gerard A; Peyrichon ML; Vidal M; Barnel C; Sauerwein W; Carnicer A; Angellier G; Mathis TM; Mishra KK; Thariat J; Herault J
Cancer Radiother; 2022 Nov; 26(8):1027-1033. PubMed ID: 35803862
[TBL] [Abstract][Full Text] [Related]
9. A Geant4 based simulation platform of the HollandPTC R&D proton beamline for radiobiological studies.
Groenendijk CF; Rovituso M; Lathouwers D; Brown JMC
Phys Med; 2023 Aug; 112():102643. PubMed ID: 37523926
[TBL] [Abstract][Full Text] [Related]
10. Practice Patterns Analysis of Ocular Proton Therapy Centers: The International OPTIC Survey.
Hrbacek J; Mishra KK; Kacperek A; Dendale R; Nauraye C; Auger M; Herault J; Daftari IK; Trofimov AV; Shih HA; Chen YE; Denker A; Heufelder J; Horwacik T; Swakoń J; Hoehr C; Duzenli C; Pica A; Goudjil F; Mazal A; Thariat J; Weber DC
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):336-343. PubMed ID: 27084651
[TBL] [Abstract][Full Text] [Related]
11. Development and verification of an analytical algorithm to predict absorbed dose distributions in ocular proton therapy using Monte Carlo simulations.
Koch NC; Newhauser WD
Phys Med Biol; 2010 Feb; 55(3):833-53. PubMed ID: 20071765
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of the Dynamic Collimation Monte Carlo simulation package for pencil beam scanning proton therapy.
Nelson NP; Culberson WS; Hyer DE; Geoghegan TJ; Patwardhan KA; Smith BR; Flynn RT; Yu J; Rana S; Gutiérrez AN; Hill PM
Med Phys; 2021 Jun; 48(6):3172-3185. PubMed ID: 33740253
[TBL] [Abstract][Full Text] [Related]
13. Improved lateral penumbra for proton ocular treatments on a general-purpose spot scanning beamline.
Saini J; Maes D; Regmi R; Fung A; Bloch C; Schwarz M; Stacey A; Chen J; Rengan R; Halasz L
Phys Med; 2023 Mar; 107():102551. PubMed ID: 36867911
[TBL] [Abstract][Full Text] [Related]
14. Commissioning and validation of a novel commercial TPS for ocular proton therapy.
Wulff J; Koska B; Heufelder J; Janson M; Bäcker CM; Siregar H; Behrends C; Bäumer C; Foerster A; Bechrakis NE; Timmermann B
Med Phys; 2023 Jan; 50(1):365-379. PubMed ID: 36195575
[TBL] [Abstract][Full Text] [Related]
15. Experimental depth dose curves of a 67.5 MeV proton beam for benchmarking and validation of Monte Carlo simulation.
Faddegon BA; Shin J; Castenada CM; Ramos-Méndez J; Daftari IK
Med Phys; 2015 Jul; 42(7):4199-210. PubMed ID: 26133619
[TBL] [Abstract][Full Text] [Related]
16. Benchmarking a GATE/Geant4 Monte Carlo model for proton beams in magnetic fields.
Padilla-Cabal F; Alejandro Fragoso J; Franz Resch A; Georg D; Fuchs H
Med Phys; 2020 Jan; 47(1):223-233. PubMed ID: 31661559
[TBL] [Abstract][Full Text] [Related]
17. Microdosimetric measurements of a monoenergetic and modulated Bragg Peaks of 62 MeV therapeutic proton beam with a synthetic single crystal diamond microdosimeter.
Verona C; Cirrone GAP; Magrin G; Marinelli M; Palomba S; Petringa G; Rinati GV
Med Phys; 2020 Nov; 47(11):5791-5801. PubMed ID: 32974938
[TBL] [Abstract][Full Text] [Related]
18. Spread-out Bragg peak proton FLASH irradiation using a clinical synchrocyclotron: Proof of concept and ion chamber characterization.
Darafsheh A; Hao Y; Zhao X; Zwart T; Wagner M; Evans T; Reynoso F; Zhao T
Med Phys; 2021 Aug; 48(8):4472-4484. PubMed ID: 34077590
[TBL] [Abstract][Full Text] [Related]
19. An initial systematic study of the linear energy transfer distributions of a proton beam under a transverse magnetic field.
Fujii Y; Ueda H; Umegaki K; Matsuura T
Med Phys; 2022 Mar; 49(3):1839-1852. PubMed ID: 35124798
[TBL] [Abstract][Full Text] [Related]
20. Experimental validation of the TOPAS Monte Carlo system for passive scattering proton therapy.
Testa M; Schümann J; Lu HM; Shin J; Faddegon B; Perl J; Paganetti H
Med Phys; 2013 Dec; 40(12):121719. PubMed ID: 24320505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
